NET Recovery Launches National Treatment Program Amid Addiction Crisis
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2025
0mins
Should l Buy DLPN?
Source: Newsfilter
- Innovative Treatment Device: NET Recovery's NET Device™ is FDA-cleared, with research indicating it can significantly reduce opioid and stimulant use. Patients using the device for over 24 hours during opioid withdrawal reported fewer days of drug use in the three months post-discharge, highlighting its potential in addiction treatment.
- National Launch Program: The company has launched a national treatment program aimed at expanding access to non-pharmacological support for patients across the U.S. This initiative allows patients to receive withdrawal relief and early stabilization support from home for the first time, reducing barriers related to cost, geography, and stigma.
- Research Findings Release: A recent peer-reviewed study shows the NET Device™ as the first medical device to demonstrate a reduction in both opioid and stimulant use, underscoring its significance in addressing the addiction crisis. CEO Joe Winston noted that quick and safe withdrawal relief helps patients stay in treatment longer, increasing the likelihood of long-term recovery.
- Brand Communication Strategy: Elle Communications is tasked with establishing NET Recovery's brand, aiming to reshape public and medical perceptions of opioid withdrawal management. Through comprehensive strategic communication services, Elle ensures NET Recovery effectively conveys the value of its treatment solutions, engaging diverse stakeholders' attention and support.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DLPN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DLPN
Wall Street analysts forecast DLPN stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.650
Low
5.00
Averages
5.00
High
5.00
Current: 1.650
Low
5.00
Averages
5.00
High
5.00

No data
About DLPN
Dolphin Entertainment, Inc. is an independent entertainment marketing and production company. Through its subsidiaries, it provides marketing and publicity services to various brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, lifestyle and charitable industries. It operates in three divisions: Dolphin Entertainment, Dolphin Marketing and Dolphin Ventures. Dolphin Entertainment division is engaged in producing television shows, digital content and feature films. It partners with IMAX and has projects including The Blue Angels and offers quality storytelling and content creation. Dolphin Marketing division is engaged in public relations, influencer marketing, branding strategy, talent booking and special events. The Dolphin Ventures division leverages cross-marketing acumen and business development relationships to create, launch and/or accelerate ideas and products, events and content in its areas of expertise.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Film Reboot: Directed by Academy Award nominee Hubert Davis, Youngblood premiered in Los Angeles, reimagining the 1986 classic hockey film to attract a new generation while retaining the original's intense emotion and swagger.
- Cultural Impact: The film's release follows Olympic victories by the U.S. men's and women's national teams, reflecting hockey's growing significance in mainstream entertainment, particularly among younger audiences.
- Media Recommendation: Selected by The New York Times as a 'What to Watch' recommendation, the film's visibility and audience anticipation are likely to boost its box office performance.
- Production Team: Produced by Academy Award and Emmy Award-nominated Aircraft Pictures in collaboration with multiple production companies, the film showcases new opportunities for hockey storytelling in modern entertainment.
See More
- Innovative Treatment Device: NET Recovery's NET Device™ is FDA-cleared, with research indicating it can significantly reduce opioid and stimulant use. Patients using the device for over 24 hours during opioid withdrawal reported fewer days of drug use in the three months post-discharge, highlighting its potential in addiction treatment.
- National Launch Program: The company has launched a national treatment program aimed at expanding access to non-pharmacological support for patients across the U.S. This initiative allows patients to receive withdrawal relief and early stabilization support from home for the first time, reducing barriers related to cost, geography, and stigma.
- Research Findings Release: A recent peer-reviewed study shows the NET Device™ as the first medical device to demonstrate a reduction in both opioid and stimulant use, underscoring its significance in addressing the addiction crisis. CEO Joe Winston noted that quick and safe withdrawal relief helps patients stay in treatment longer, increasing the likelihood of long-term recovery.
- Brand Communication Strategy: Elle Communications is tasked with establishing NET Recovery's brand, aiming to reshape public and medical perceptions of opioid withdrawal management. Through comprehensive strategic communication services, Elle ensures NET Recovery effectively conveys the value of its treatment solutions, engaging diverse stakeholders' attention and support.
See More
Record Financial Performance: Dolphin Entertainment reported a record revenue of $14.1 million for Q2 2025, marking a 23% year-over-year increase and achieving positive adjusted operating income, while launching its Tastemakers division to enhance long-term value creation.
Cost Reduction and Margin Expansion: The company anticipates significant annualized savings from lease expirations and loan repayments by late 2028, which will contribute to margin expansion and increased cash flow, alongside ongoing investments in new revenue streams.
See More








